Integral Health Asset Management, LLC / ALNY
Integral Health Asset Management, LLC’s Alnylam Pharmaceuticals Inc Position
Does Integral Health Asset Management, LLC own Alnylam Pharmaceuticals Inc (ALNY)? Not currently — the last reported position was 60.0K shares worth $24M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$24M
Q4 2025
Shares
60.0K
% of Portfolio
+1.18%
Quarters Held
19
position exited
Position History ALNY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 60.0K | $24M | +1.18% |
| Q3 2025 | 60.0K | $27M | +1.85% |
| Q2 2025 | 55.0K | $18M | +1.64% |
| Q1 2025 | 50.0K | $14M | +1.44% |
| Q4 2024 | 45.0K | $11M | +0.90% |
| Q3 2024 | 25.0K | $7M | +0.77% |
| Q1 2024 | 50.0K | $7M | +0.69% |
| Q4 2023 | 45.0K | $9M | +1.17% |
| Q2 2023 | 52.0K | $10M | +1.22% |
| Q1 2023 | 20.0K | $4M | +0.81% |
| Q4 2022 | 35.0K | $8M | +1.75% |
| Q3 2022 | 70.0K | $14M | +2.72% |
| Q2 2022 | 47.0K | $7M | +1.41% |
| Q4 2021 | 20.0K | $3M | +0.94% |
| Q3 2021 | 25.0K | $5M | +1.36% |
| Q2 2021 | 25.0K | $4M | +1.17% |
| Q1 2021 | 40.0K | $6M | +1.61% |
| Q4 2020 | 15.0K | $2M | +0.58% |
| Q3 2020 | 25.0K | $4M | +1.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Integral Health Asset Management, LLC’s full portfolio or all institutional holders of ALNY.